AI image-generation pioneer Midjourney has announced a dramatic shift into healthcare with the formation of Midjourney Medical, unveiling a prototype for a radical full-body imaging system called Ultrasonic CT. The technology, which combines a water-filled chamber, a ring of 500,000 ultrasonic transmitters/receivers, and proprietary AI reconstruction, aims to produce MRI-like volumetric images in just 60 seconds — a process that typically takes 30 minutes or more in conventional scanners.
The announcement, made on June 18, 2026, comes with a strategic framework that could reshape preventive healthcare. Midjourney plans to begin human trials within the next year, initially offering body-composition maps while pursuing FDA clearance for diagnostic use. A wellness spa — the first Midjourney Spa — is scheduled to open in San Francisco in late 2027, offering hot tubs, saunas, cold plunges, and non-diagnostic scans as a lifestyle experience. The company’s long-term goal: deploy 50,000 scanners globally by 2031, capable of performing one billion full-body scans per month.
Key to the hardware is a co-development agreement with Butterfly Network (NYSE: BFLY), the semiconductor-ultrasound company, disclosed in November 2025. Butterfly is supplying 40 Ultrasound-on-Chip modules per prototype, with payments up to $74 million over five years. CEO Joseph DeVivo emphasized the shift from treating illness to prevention, calling the device “a continuous window into your health.”
Midjourney’s pivot has attracted attention beyond medicine because of its funding model. The company remains entirely community-backed, with no outside venture capital, funding moonshots through revenue from its popular AI image product. Founder David Holz has framed the scanner as a public good, claiming that early and frequent imaging could eventually prevent 30% of all deaths and 50% of healthcare costs—a statement both ambitious and, in its preventive logic, broadly supported by clinicians.
For the crypto and frontier-tech world, the move reinforces two narratives. First, it exemplifies the trend of top AI labs moving beyond chat interfaces into physical infrastructure and hardware. Second, the decentralized-AI thesis — which sees centralized control of powerful models as a systemic risk — was supercharged this month when a single export-control directive pulled multiple Anthropic models offline. Midjourney’s community-funded, independent approach offers a counter-example to the VC‑fueled concentration that dominates the AI sector.
Competitors are also pressing into healthcare: OpenAI has launched ChatGPT Health and Clinician tools, Anthropic is expanding into clinical research, and Elon Musk has promoted Grok for medical advice. However, none have taken the hardware route Midjourney is charting. The company’s candor about unsolved computational challenges — turning terabytes-per-second of acoustic data into clean images is still a work in progress — adds to the project’s credibility as a long-term research bet rather than a polished product.
While the privacy implications of harvesting intimate biological data at scale remain unresolved, Midjourney’s move positions it as a lab that “asks what we can build for people … and what we can change within the foundations of the human experience.”
